Dilazep, a nucleoside transporter inhibitor, modulates cell cycle progression and DNA synthesis in rat mesangial cells in vitro

Cell Proliferation

Volumn 33, Issue 1, 2000, Pages 19-28

  Sakumura, T ^a   Fujii, Z ^a   Umemoto, S ^a   Murakami, T ^b   Kawata, Y ^a   Fujii, K ^a   Minami, M ^a   Sasaki, K ^a   Matsuzaki, M ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL SANYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; CELL DNA; DILAZEP;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; FLOW CYTOMETRY; HISTOGRAM; MALE; MESANGIUM CELL; NONHUMAN; RAT;

ANIMALS; BROMODEOXYURIDINE; CARRIER PROTEINS; CELL CYCLE; CELL DIVISION; DILAZEP; DNA; FLOW CYTOMETRY; GLOMERULAR MESANGIUM; KINETICS; MALE; MEMBRANE PROTEINS; NUCLEOSIDE TRANSPORT PROTEINS; NUCLEOSIDES; RATS; RATS, WISTAR; S PHASE;

ANIMALIA;

EID: 0034105291     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2000.00145.x     Document Type: Article

References (29)

1. Bear HP, Serigesf V, Ogbunude POJ, Moorji A. (1991) Miofiazine derivatives: their potential as in vivo nucleoside transport inhibitors and components of antiparasitic combination treatment. In: Imai S, Nakazawa M, eds. Role of Adenosine and Adenosine Nucleosides in the Biological System. Amsterdam, Elsevier Science Publishers, 161.
2. Belle VH, Goossens F, Wynant J. (1987) Formation and release of purine cataborites during hypoperfusion, anoxia, and ischemia. Am. J. Physiol. 252, H886.
3. Cai J, Lee CW. (1996) Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF-7 breast cancer cells. Biochem. J. 320, 991.
4. Cass CE. (1995) Nucleoside transport. In: Georgopapadakou NH., ed. Drug Transport in Antimicrobial and Anticancer Chemotherapy. New York, Marcel Dekker, 403.
5. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW. (1983) Flow cytometric measurement of total RNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA. 80, 5573.
6. Ethier MF, Dobson JG Jr. (1997) Adenosine stimulation of DNA synthesis in human endothelial cells. Am. J. Physiol. 202, H1470.
7. Floege J, Bupns MW, Alpers C et al. (1992) Glomerular cell proliferation and PDGF expression precede glomerulonephritis in the remnant kidney model. Kidney Internl. 41, 279.
8. Griffiths M, Beaumout N, Yao SYM et al. (1997) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nature Med. 3, 89.
9. Hara A, Abiko Y. (1996) Protective effects of dilazep and its novel derivative, K-7259, on mechanical and metabolic derangement induced by hydrogen peroxide in the isolated perfused rat heart. J. Pharmacol. Exp. Ther. 227, 565.
10. Harper PA, Robinson JM, Hoover RL, Wright TC, Kapnosky MJ. (1984) Improved methods for culturing rat glomerular cells. Kidney Int. 26, 875.
11. Hogue N, Hogue ANE, Hashizume H, Ichihara K, Abiko Y. (1996) K-7259, a novel dilazep derivative, and d-propranolol attenuate H202-induced cell damage. J. Pharmacol. Exp. Ther. 277, 207.
12. Iida H, Seifert R, Alpers CE et al. (1988) Platelet-derived growth factor (PDGF) and PDGF receptor are induced mesangial proliferativc nephritis in the rat. Proc. Natl. Acad. Sci. USA. 88, 6560.
13. Inage H, Koyama A, Narita M, Tojo S. (1985) The effects of the antiplatelet agent, dipyridamole and dilazep dihydrochloride on the in vivo platelet function and proteinuria. Jpn. J. Nephrol. 27, 1261.
14. Ishibashi T, Hara A, Abiko Y. (1987) Relationship between coronary flow and adenosine release during severe and mild hypoxia in the isolated perfused rat heart with special reference to time-course change. Heart Vessel 3, 113.
15. Ishikawa S, Kawasumi M, Kusaka I, Komatsu N, Iwao N, Saito T. (1994) Extracellular ATP promotes cellular growth of glomerular mesangial cells mediated via phospholipase C. Biochem. Biophys. Res. Comn. 272, 234.
16. Kawata Y, Fujii Z, Sakumura T, Kitano M, Suzuki N, Matsuzaki M. (1998) High pressure conditions promote the proliferation of rat cultured mesangia in vitro. Biochem. Biophys. Acta. 1401, 195.
17. Koide H, Totsuka Y, Sugisaki T et al. (1995) Clinical effect of the antiplatelet drug, dilazep dihydrochloride, in patients at the microalbuminuric stage of diabetic nephropathy a multi-center study. Jpn J. Nephrol. 37, 644.
18. Maruhama Y, Sasaki M, Mukaida H et al. (1985) Clinical effect of dilazep (Commelian kowa) on early diabetic nephropathy. Jpn Pharmacol. 7her. 18, 4689.
19. Murakami T, Li X, Gong J, Bhatia U, Traganos F, Darzynkiewics Z. (1995) Induction of apoptosis by 5-azacytidine: drug concentration-dependent differences in cell cycle specificity. Cancer Res. 55, 3093.
20. Nagase M, Kobayashi S, Sakakibara K, Honda N. (1985) Amelioration of albuminuria induced by dilazep administration in aminonueleoside nephrosis of rat. Jpn J. Nephrol. 27, 385.
21. Nakazawa K, Moriya T, Kasai S et al. (1993) Dilazep prevents glomerulosclerosis in accelated Masugi nephritis in the rat. Jpn J. Nephrol. 35, 329.
22. Plagemann PGW, Woffendin C. (1988) Spicces differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine. Bioochem. Biophys. Acta. 969, 1.
23. Silver BJ, JaffeR FE, Abboud HE. (1989) Platelet-derived growth factor synthesis in mesangiai cells. Induction by multiple peptide mitogens. Proc. Natl. Acad. Sci. USA. 186, 1046.
24. Tajiri Y, Umeda F, Kunisaki M et al. (1989) Effect of dilazep hydrochloride on urinary albumin excretion in patients with diabetic nephropathy. Therapeut. Res. 10, 5335.
25. Tanabe S, Tamaki T, Wada Y, Sumiyoshi A, Funahara Y. (1992) Cytoprotective effect of dilazep on hydrogen peroxide perturbed vascular endothelial cells. Southeast Asian J. Trop. Med. Public Health 23, 120.
26. Yamamoto M, Fukui M, Kuramoto T, Kabuki K, Tomino Y. (1995) Effects of the antiplatelet drug, dilazep dihydrochloride, on anionic site and extracellular matrix (ECM) components in glomerular basement membrane of STZ-induced diabetic rats. J. Clin. Lab Anal. 9, 380.
27. Yasunaga K, Mase K, Nakajima K, Yamamoto S, Nagakura M. (1988) Potential effectiveness of minidose aspirin combined with dilazep in antiplatelet therapy. Jpn. J. Clin. Pharmicol. Ther. 19, 453.
28. Yoshida H, Kanatsu K, Muso E et al. (1994) Effects of an antiplatelet drug (dilazep) in lgA nephropathy: comparison of clinical effects with renal biopsy findings. Jpn. J. Nephrol. 36, 339.
29. Young JD, Jarvis SM. (1983) Nucleoside transport in animal cells. Biosci. Res. 3, 309.